Therefore, our findings not only offer insight into the functional role of TIMP-1, as an inhibitor or MMP-9, with potential neuroprotective effects, but also support its potential as a key molecule in cytokine-mediated treatment for AD. This evidence concerns the gene TIMP1 and Alzheimer disease.